STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Companyâs principal products are ICLs used in refractive surgery, including its EVO family of lenses.
äŒæ¥ã³ãŒãSTAA
äŒç€ŸåSTAAR Surgical Co
äžå Žæ¥Feb 24, 1992
æé«çµå¶è²¬ä»»è
ãCEOãFarrell (Stephen C)
åŸæ¥å¡æ°1157
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 24
æ¬ç€Ÿæåšå°1911 Walker Ave
éœåžMONROVIA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·91016
é»è©±çªå·16263037902
ãŠã§ããµã€ãhttps://www.staar.com/
äŒæ¥ã³ãŒãSTAA
äžå Žæ¥Feb 24, 1992
æé«çµå¶è²¬ä»»è
ãCEOãFarrell (Stephen C)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã